Natera Retained Earnings (Accumulated Deficit) 2014-2024 | NTRA

Natera retained earnings (accumulated deficit) from 2014 to 2024. Retained earnings (accumulated deficit) can be defined as profits reinvested in the corporation after dividends have been paid out.
  • Natera retained earnings (accumulated deficit) for the quarter ending June 30, 2024 were $-2.482B, a 13.34% increase year-over-year.
  • Natera retained earnings (accumulated deficit) for 2023 were $-2.377B, a 22.38% increase from 2022.
  • Natera retained earnings (accumulated deficit) for 2022 were $-1.943B, a 39.27% increase from 2021.
  • Natera retained earnings (accumulated deficit) for 2021 were $-1.395B, a 50.09% increase from 2020.
Natera Annual Retained Earnings (Accumulated Deficit)
(Millions of US $)
2023 $-2,377
2022 $-1,943
2021 $-1,395
2020 $-929
2019 $-699
2018 $-575
2017 $-446
2016 $-346
2015 $-250
2014 $-180
2013 $-175
Natera Quarterly Retained Earnings (Accumulated Deficit)
(Millions of US $)
2024-06-30 $-2,482
2024-03-31 $-2,445
2023-12-31 $-2,377
2023-09-30 $-2,299
2023-06-30 $-2,190
2023-03-31 $-2,080
2022-12-31 $-1,943
2022-09-30 $-1,800
2022-06-30 $-1,679
2022-03-31 $-1,533
2021-12-31 $-1,395
2021-09-30 $-1,254
2021-06-30 $-1,103
2021-03-31 $-987
2020-12-31 $-929
2020-09-30 $-853
2020-06-30 $-795
2020-03-31 $-735
2019-12-31 $-699
2019-09-30 $-664
2019-06-30 $-641
2019-03-31 $-608
2018-12-31 $-575
2018-09-30 $-543
2018-06-30 $-513
2018-03-31 $-479
2017-12-31 $-446
2017-09-30 $-437
2017-06-30 $-410
2017-03-31 $-382
2016-12-31 $-346
2016-09-30 $-308
2016-06-30 $-282
2016-03-31 $-259
2015-12-31 $-250
2015-09-30 $-227
2015-06-30 $-209
2015-03-31
2014-12-31
2014-09-30
2014-06-30
2013-12-31 $-175
Sector Industry Market Cap Revenue
Medical Medical Services $16.570B $1.083B
Natera, Inc. offers genetic testing and diagnostics with proprietary bioinformatics and molecular technology. Natera, Inc. is headquartered in San Carlos, California.
Stock Name Country Market Cap PE Ratio
Elevance Health (ELV) United States $98.658B 12.24
Cencora (COR) United States $49.082B 18.10
DiDi Global (DIDIY) China $23.427B 0.00
ICON (ICLR) Ireland $17.504B 15.59
Viatris (VTRS) United States $15.624B 4.81
Avantor (AVTR) United States $15.178B 22.75
Revvity (RVTY) United States $14.682B 25.50
BioMerieux (BMXMF) France $13.087B 0.00
CochLear (CHEOY) Australia $12.998B 0.00
Solventum (SOLV) United States $12.357B 0.00
Doximity (DOCS) United States $11.372B 67.31
Medpace Holdings (MEDP) United States $11.301B 31.84
Charles River Laboratories (CRL) United States $11.285B 21.81
HealthEquity (HQY) United States $8.756B 47.52
Sonic Healthcare (SKHHY) Australia $8.590B 0.00
Bausch + Lomb (BLCO) Canada $7.202B 33.53
Life Times (LTH) United States $5.139B 34.01
Sotera Health (SHC) United States $4.509B 24.12
Organon (OGN) United States $4.144B 4.18
Surgery Partners (SGRY) United States $3.996B 44.27
BrightSpring Health Services (BTSG) United States $3.489B 74.22
PACS (PACS) United States $3.347B 0.00
Alignment Healthcare (ALHC) United States $2.580B 0.00
Concentras Parent (CON) United States $2.505B 0.00
Ardent Health Partners (ARDT) United States $2.471B 0.00
Premier (PINC) United States $2.314B 11.55
Ryman Healthcare (RYHTY) New Zealand $2.036B 0.00
GeneDx Holdings (WGS) United States $2.016B 0.00
GoodRx Holdings (GDRX) United States $1.856B 48.90
Teladoc Health (TDOC) United States $1.689B 0.00
Progyny (PGNY) United States $1.540B 27.08
Pediatrix Medical (MD) United States $1.371B 13.41
Establishment Labs Holdings (ESTA) $1.266B 0.00
CareDx (CDNA) United States $1.252B 0.00
AMN Healthcare Services Inc (AMN) United States $1.058B 7.16
Embecta (EMBC) United States $0.910B 6.07
Agilon Health (AGL) United States $0.890B 0.00
InnovAge Holding (INNV) United States $0.809B 0.00
QDM (QDMI) Hong Kong, SAR China $0.790B 20.69
SBC Medicals (SBC) United States $0.723B 0.00
Auna S.A (AUNA) Luxembourg $0.516B 0.00
Sonida Senior Living (SNDA) United States $0.459B 0.00
DocGo (DCGO) United States $0.411B 15.46
Enhabit (EHAB) United States $0.403B 34.83
COMPASS Pathways (CMPS) United Kingdom $0.363B 0.00
LifeMD (LFMD) United States $0.308B 0.00
Sera Prognostics (SERA) United States $0.248B 0.00
ModivCare (MODV) United States $0.231B 12.54
Beauty Health (SKIN) United States $0.218B 0.00
Biodesix (BDSX) United States $0.205B 0.00
Nutex Health (NUTX) United States $0.152B 0.00
MultiPlan (MPLN) United States $0.137B 0.00
Ascend Wellness Holdings (AAWH) United States $0.107B 0.00
So-Young (SY) China $0.088B 21.28
Singular Genomics Systems (OMIC) United States $0.057B 0.00
Harvard Apparatus Regenerative Technology (HRGN) United States $0.054B 0.00
OncoCyte (OCX) United States $0.049B 0.00
NeueHealth (NEUE) United States $0.042B 1.10
Co-Diagnostics (CODX) United States $0.038B 0.00
IceCure Medical (ICCM) Israel $0.028B 0.00
NeuroOne Medical Technologies (NMTC) United States $0.028B 0.00
Pheton Holdings (PTHL) China $0.027B 0.00
Oncology Institute (TOI) United States $0.020B 0.00
SeaStar Medical Holding (ICU) United States $0.012B 0.00
XWELL (XWEL) United States $0.009B 0.00
Intelligent Bio Solutions (INBS) United States $0.008B 0.00
BioNexus Gene Lab (BGLC) $0.006B 0.00
KindlyMD (KDLY) United States $0.005B 0.00
ISpecimen (ISPC) United States $0.004B 0.00
NewGenIvf Group (NIVF) Thailand $0.003B 0.00
Aclarion (ACON) United States $0.002B 0.00
Cano Health (CANOQ) United States $0.001B 0.00